0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2023/01/31 14:45:01
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Type |
Post Insult Time Value |
Post Insult Time Unit |
Record ID |
Study ID |
MW |
hematocrit |
nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
erythrocyte quantity |
male |
0 days
| 8 |
38.0 |
% |
1.0 |
2.83 |
hematocrit analysis |
0.0 |
5/6 nephrectomy |
28 |
days |
100987 |
2561 |
MW |
hematocrit |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
erythrocyte quantity |
male |
0 days
| 8 |
40.0 |
% |
1.0 |
2.83 |
hematocrit analysis |
0.0 |
5/6 nephrectomy |
28 |
days |
100986 |
2561 |
MW |
hematocrit |
nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
erythrocyte quantity |
male |
0 days
| 8 |
36.0 |
% |
1.0 |
2.83 |
hematocrit analysis |
0.0 |
5/6 nephrectomy |
28 |
days |
100988 |
2561 |
|